Reviewed by: TRT Locator's Medical Advisory Board.
> This article summarizes and credits content from the Huberman Lab YouTube video on peptide therapeutics, hosted by Dr. Andrew Huberman. All scientific claims, protocol discussion, and category frameworks featured here are drawn from that video. We strongly recommend watching the original for full context.
Peptide therapy for men spans four distinct categories: tissue repair, growth hormone optimization, longevity, and vitality. In a detailed episode, neuroscientist Andrew Huberman walks through how these compounds work, which are FDA-approved, which exist in a murky gray market, and why all of them demand physician oversight before anyone considers using them.
What are peptides, and how do they differ from testosterone?
A peptide is a short chain of amino acids, typically between 2 and 50 amino acids in length. As Huberman explains, peptides act as hormones, proteins, or neuromodulators in the body. Familiar examples include insulin, which regulates blood sugar, and oxytocin, the neuropeptide involved in social bonding.
Where testosterone is a steroid hormone that directly signals cells to take on male characteristics, peptides work more like keys that unlock a cascade of downstream processes. When a peptide binds to a receptor, it can trigger what Huberman calls a "bucket brigade" of cellular activity: growth, cell migration, blood vessel development, or hormone production. That pleotropic quality is both the appeal and the risk. A single peptide can influence many different organ systems at once, which means the dose matters more than most users appreciate.
Huberman draws a clear regulatory map: some therapeutic peptides are FDA-approved and available by prescription, some exist on a gray market through online compounding pharmacies with variable quality control, and some are outright black-market compounds that frequently arrive contaminated with lipopolysaccharide (LPS), a bacterial byproduct that can cause serious immune reactions. The sourcing decision alone shapes whether a peptide is a medical tool or a gamble (Huberman Lab, 2024).
Tissue repair: BPC-157 and Thymosin Beta 4
Two peptides dominate the tissue healing space, and they work through different mechanisms.
BPC-157 (Body Protection Compound) is naturally present in gastric juices. The synthesized version is used to encourage cellular turnover, cell migration, and angiogenesis, which is the development of new blood supply to injured tissue. Animal studies show BPC-157 can recognize damaged blood vessels and promote the growth of new vasculature and fibroblasts directly at the injury site, making it potentially useful for muscle tears, ligament damage, and tendon injuries.
The tradeoff is real and worth naming clearly. Because BPC-157 promotes angiogenesis through VEGF (vascular endothelial growth factor), it carries a tumor growth risk. Tumors depend on blood supply to grow. A user who has an undetected tumor could accelerate its progression. Huberman is direct on this point: anyone considering BPC-157 should get a comprehensive health screening first (Huberman Lab, 2024).
Thymosin Beta 4 (TB500) is naturally secreted by the thymus, a gland that is most active in childhood and declines with age. It promotes stem cell proliferation and the growth of the extracellular matrix. The primary use case is enhancing the rate and thoroughness of wound healing while minimizing scar tissue formation. Like BPC-157, it is not FDA-approved for these applications and exists in the gray-market compounding space.
Growth hormone secretagogues: sermorelin, tesamorelin, and the rest
Growth hormone levels decline by roughly 15 percent per decade after age 30. This drop is real, and it correlates with increases in body fat, reductions in lean mass, and poorer sleep quality. Growth hormone secretagogues are peptides designed to nudge the pituitary gland into releasing more of its own GH rather than replacing it directly.
Huberman divides these into two categories.
The first group are GHRH analogues, which mimic naturally occurring growth hormone-releasing hormone. Sermorelin is FDA-approved for treating short stature in children and increases circulating GH and IGF-1. Tesamorelin (sold as Egrifta) is FDA-approved to reduce visceral fat in HIV patients and has a longer duration of action than sermorelin. CJC-1295 is a longer-acting variant, though Huberman flags its safety record: a death in a clinical trial was linked to cardiovascular dysfunction, which makes it a compound to treat with particular caution (Huberman Lab, 2024).
The second group are GHRPs and ghrelin mimics. Ipamorelin increases GH release and simultaneously suppresses somatostatin, the hormone that acts as a brake on GH production. Hexarelin is a potent GH stimulator, but Huberman notes it can desensitize receptors over time and elevate prolactin, which suppresses libido. MK-677 is an oral version in this class, but it can raise cortisol and prolactin, making those hormones worth monitoring closely.
The risks across this entire category are consistent: elevated GH levels can cause carpal tunnel syndrome, changes in facial bone structure with prolonged use, and a distended gut. Most critically, they increase the risk of growing existing tumors, the same concern as BPC-157. Huberman also shares his own experience with sermorelin: it improved his deep sleep but significantly depleted REM sleep, which he considers a serious enough trade-off that he stopped using it.
Longevity: epitalon
Epitalon is a synthetic peptide that mimics epithalamion, a compound secreted by the pineal gland. Animal studies suggest epitalon can increase telomere length, suppress tumor growth (notably the reverse of BPC-157 and the GH secretagogues on this point), and help recalibrate circadian rhythms by influencing melatonin patterns.
The honest summary from Huberman is that epitalon is intriguing but unproven in humans. There are currently no human clinical trials confirming life extension. The animal data is interesting enough to have attracted serious researchers, but a gap between rodent models and human physiology is the norm in longevity science, not the exception (Huberman Lab, 2024).
Vitality, libido, and the melanocortin system
The final category is where TRT users are most likely to encounter peptides used alongside their hormone therapy.
Melanotan peptides mimic melanocyte-stimulating hormone. Melanotan 1 primarily causes skin tanning. Melanotan 2 and related compounds can cross the blood-brain barrier and produce increases in libido and mood while decreasing appetite. PT-141 (Vyleesi) is the FDA-approved version of this class, approved for female hypoactive sexual desire disorder and used off-label by men. Side effects include nausea, flushing, and temporary blood pressure elevation.
Kisspeptin is one of the more recently characterized peptides in this space. It works by triggering the hormonal cascade that drives testosterone and estrogen production, stimulating GnRH (gonadotropin-releasing hormone) which then signals the pituitary to release LH and FSH. It has an established clinical use in treating hypothalamic amenorrhea in women. For men, it has attracted interest as a way to support the body's own testosterone production rather than supplementing exogenously. Huberman notes that because kisspeptin was only recently identified, its full range of effects remains incompletely mapped (Huberman Lab, 2024).
